SCM Lifescience Co., Ltd. (KOSDAQ: 298060)
South Korea
· Delayed Price · Currency is KRW 1,700.00
-100.00 (-5.56%)
Nov 15, 2024, 9:00 AM KST
SCM Lifescience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -15,647 | -23,961 | -22,930 | -22,519 | -9,633 | -42,554 | Upgrade
|
| Depreciation & Amortization | 792.35 | 839.44 | 1,041 | 1,136 | 1,231 | 1,163 | Upgrade
|
| Loss (Gain) From Sale of Assets | 259.04 | - | - | 0.48 | 1.38 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 59.16 | 59.16 | - | - | -15,229 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 3,691 | 10,673 | 11,650 | 9,999 | 6,043 | 5,934 | Upgrade
|
| Stock-Based Compensation | 140.61 | 614.04 | 664.68 | -1,974 | 4,297 | 1,571 | Upgrade
|
| Other Operating Activities | 3.15 | 118.18 | -1,218 | 374.22 | 2,739 | 24,622 | Upgrade
|
| Change in Accounts Receivable | -3.14 | -100.78 | 11.17 | 1.8 | -4.2 | -14.39 | Upgrade
|
| Change in Inventory | -201.36 | -289.35 | 176.97 | -243.66 | 273.53 | -254.84 | Upgrade
|
| Change in Accounts Payable | 1.31 | - | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -363.5 | -88.33 | -579.09 | -178.57 | -609.09 | 1,111 | Upgrade
|
| Operating Cash Flow | -11,268 | -12,136 | -11,184 | -13,404 | -10,890 | -8,422 | Upgrade
|
| Capital Expenditures | -1,851 | -235.57 | -504.83 | -676 | -1,480 | -9,273 | Upgrade
|
| Sale (Purchase) of Intangibles | -272.16 | -8.05 | - | - | -7.9 | -5 | Upgrade
|
| Investment in Securities | -2,068 | -7,265 | 16,000 | 16,957 | -23,407 | -992 | Upgrade
|
| Other Investing Activities | 85.57 | 498.83 | -496.86 | -489.46 | 1,238 | 0.79 | Upgrade
|
| Investing Cash Flow | -4,106 | -7,010 | 14,998 | 15,791 | -23,657 | -10,270 | Upgrade
|
| Short-Term Debt Issued | - | - | 2,000 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 3,630 | - | - | 6,100 | Upgrade
|
| Total Debt Issued | - | - | 5,630 | - | - | 6,100 | Upgrade
|
| Short-Term Debt Repaid | - | -2,000 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -148.91 | -6,091 | -474.9 | -512.04 | -454.06 | Upgrade
|
| Total Debt Repaid | -168.6 | -2,149 | -6,091 | -474.9 | -512.04 | -454.06 | Upgrade
|
| Net Debt Issued (Repaid) | -168.6 | -2,149 | -460.78 | -474.9 | -512.04 | 5,646 | Upgrade
|
| Issuance of Common Stock | - | 19,333 | 674.38 | 907.7 | 32,263 | 2,089 | Upgrade
|
| Repurchase of Common Stock | -16.56 | -16.56 | - | - | - | - | Upgrade
|
| Other Financing Activities | 2.47 | -441.82 | -1.86 | -7.52 | -1,562 | -13.82 | Upgrade
|
| Financing Cash Flow | -182.69 | 16,725 | 211.73 | 425.29 | 30,189 | 11,718 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -15,557 | -2,421 | 4,026 | 2,813 | -4,358 | -6,974 | Upgrade
|
| Free Cash Flow | -13,120 | -12,372 | -11,689 | -14,080 | -12,370 | -17,696 | Upgrade
|
| Free Cash Flow Margin | -1475.05% | -1778.30% | -2951.85% | -3205.28% | -3865.43% | -10501.86% | Upgrade
|
| Free Cash Flow Per Share | -640.06 | -755.92 | -805.93 | -1176.70 | -1165.98 | -3361.24 | Upgrade
|
| Cash Interest Paid | 198.48 | 288.38 | 204.31 | 169.73 | 217.05 | 143.3 | Upgrade
|
| Cash Income Tax Paid | - | -29.73 | 6.69 | -45.53 | -74.57 | 62.18 | Upgrade
|
| Levered Free Cash Flow | -8,011 | -8,706 | -7,677 | -9,620 | -17,164 | -31,303 | Upgrade
|
| Unlevered Free Cash Flow | -7,900 | -8,511 | -7,527 | -9,496 | -16,847 | -29,124 | Upgrade
|
| Change in Net Working Capital | -732.54 | 1,338 | 521.07 | 67.6 | 10,427 | 14,519 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.